Premier Biosoft has acquired privately held bioinformatics company Redasoft in an effort to expand its life sciences software business.

Redasoft markets sequence analysis software dubbed Visual Cloning, which includes vector map drawing capabilities and lets users create graphical maps based on sequence data. It also provides tools for restriction site analysis as well as to search for open reading frames.

Palo Alto, Calif.-based Premier, which is also privately held, expects the new acquisition to expand its reach in the life science software market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."